Clinic and home blood pressure lowering effect of an angiotensin receptor blocker, fimasartan, in postmenopausal women with hypertension

Medicine (United States)

Volumn 95, Issue 22, 2016, Pages

  Kim, Song Yi ^a   Joo, Seung Jae ^a   Shin, Mi Seung ^b   Kim, Changsoo ^c   Cho, Eun Joo ^d   Sung, Ki Chul ^e   Kang, Seok Min ^f   Kim, Dong Soo ^g   Lee, Seung Hwan ^h   Hwang, Kyung Kuk ⁱ   Park, Jeong Bae ^j  

^a Jeju National University School of Medicine   (South Korea)

^b Gachon University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e School of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Inje University College of Medicine   (South Korea)

^h Wonju Severance Christian Hospital   (South Korea)

ⁱ Chungbuk National University College of Medicine   (South Korea)

^j Dankook University   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; FIMASARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; PYRIMIDINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR ACCIDENT; CLINIC BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HEART INFARCTION; HOME; HOME BLOOD PRESSURE; HOSPITAL; HUMAN; HYPERTENSION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE PRESSURE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED; OUTPATIENT DEPARTMENT; PULSE RATE; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

ADULT; AGED; AMBULATORY CARE FACILITIES; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; PULSE; PYRIMIDINES; REPUBLIC OF KOREA; TETRAZOLES;

EID: 84975260803     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003764     Document Type: Article

References (39)

1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25: 305-313
2. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013: 1-8
3. Yoon SS, Gu Q, Nwankwo T, et al. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension. 2015; 65: 54-61
4. Mozaffarian D, Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015; 131: e29-322
5. Kim HJ, Kim Y, Cho Y, et al. Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998-2012. Int J Cardiol. 2014; 174: 64-72
6. Taddei S. Blood pressure through aging and menopause. Climacteric. 2009; 12(Suppl 1): 36-40
7. Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy. Hypertension. 2009; 54: 11-18
8. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep. 2012; 14: 254-260
9. Pimenta E. Hypertension in women. Hypertens Res. 2012; 35: 148-152
10. Geraci TS, Geraci SA. Considerations in women with hypertension. South Med J. 2013; 106: 434-438
11. Abramson BL, Melvin RG. Cardiovascular risk in women: focus on hypertension. Can J Cardiol. 2014; 30: 553-559
12. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J. 2007; 28: 2028-2040
13. Te Riet L, van Esch JH, Roks AJ, et al. Hypertension: reninangiotensin-Aldosterone system alterations. Circ Res. 2015; 116: 960-975
14. Ibrahim MM. RAS inhibition in hypertension. J Hum Hypertens. 2006; 20: 101-108
15. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004; 43: 918-923
16. Yanes LL, Romero DG, Iliescu R, et al. Postmenopausal hypertension: role of the renin-Angiotensin system. Hypertension. 2010; 56: 359-363
17. O?Donnell E, Floras JS, Harvey PJ. Estrogen status and the renin angiotensin aldosterone system. Am J Physiol Regul Integr Comp Physiol. 2014; 307: R498-500
18. Stimpel M, Koch B, Oparil S. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide). Cardiology. 1998; 89: 271-276
19. Hayoz D, Zappe DH, Meyer MA, et al. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen. J Clin Hypertens. 2012; 14: 773-778
20. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Internet]. London: Royal College of Physicians (UK 2011 Aug. Available at http://www.ncbi.nlm.nih. gov/pubmedhealth/PMH0047679/. Accessed September 17, 2015
21. ESH/ESC. Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013; 31: 1925-1938
22. Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008; 52: 1045-1450
23. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012; 59: 212-218
24. Matsui Y, Ishikawa J, Eguchi K, et al. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension. 2011; 57: 1087-1093
25. Stergiou GS, Ntineri A, Kollias A, et al. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res. 2014; 37: 565-572
26. Park JB, Sung KC, Kang SM, Cho EJ. Safety and efficacy of fimasartan in patients with arterial hypertension (Safe-KanArb study): an open-label observational study. Am J Cardiovasc Drugs. 2013; 13: 47-56
27. Kim CS, Kim MY, Kang DR, et al. The efficacy of fimasartan for cardiovascular events and metabolic syndrome (K-MetS Study): rationale, design and participant characteristics. Pulse. 2014; 1: 177-185
28. Turnbull F, Woodward M, Neal B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008; 29: 2669-2680
29. Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens. 2008; 21: 789-798
30. Wassertheil-Smoller S, Anderson G, Psaty BM, et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women?s Health Initiative. Hypertension. 2000; 36: 780-789
31. Schulman IH, Aranda P, Raij L, et al. Surgical menopause increases salt sensitivity of blood pressure. Hypertension. 2006; 47: 1168-1174
32. Agabiti-Rosei E, Ambrosioni E, Pirelli A, et al. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause. Eur J Clin Pharmacol. 1999; 55: 185-189
33. Wassertheil-Smoller S, Psaty B, Greenland P, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA. 2004; 292: 2849-2859
34. Os I, Bratland B, Dahlö f B, et al. Female sex as an important determinant of lisinopril-induced cough. Lancet. 1992; 339: 372
35. Mirza FS, Ong P, Collins P, et al. Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women. Menopause. 2008; 15: 44-50
36. Kato T, Kikuya M, Ohkubo T, et al. Factors associated with day-byday variability of self-measured blood pressure at home: the Ohasama study. Am J Hypertens. 2010; 23: 980-986
37. Ishikura K, Obara T, Kato T, et al., J-HOME-Morning Study Group. Associations between day-by-day variability in blood pressure measured at home and antihypertensive drugs: the J-HOME-Morning study. Clin Exp Hypertens. 2012; 34: 297-304
38. Zanchetti A, Facchetti R, Cesana GC, et al. SIMONA participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005; 23: 2269-2276
39. Casiglia E, Tikhonoff V, Caffi S, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens. 2008; 26: 1983-1992